12h20
Registration and welcome coffee
12h50
Welcome Address
13h00
Opening Keynote Lecture
Hervé Broly
Executive CMC Consultant for Biologics
Merck-Serono SA, Switzerland
13h30
Track Reassessing Critical quality attributes (CQA ) for mAbs & Vaccines : latest developments
Alain Beck
Senior Director, Biologics CMC & Developability
Pierre Fabre, France
Associate editor
mAbs
Koen Sandra
CEO
RIC group, Belgium
Kowid Ho
Technical Regulatory (CMC) Policy Biologics
F. Hoffmann-La Roche Ltd., Switzerland
Track Critical quality attributes (CQA) for Cell & Gene Therapy : new advancements
Olivier Maurion
Director « GoCommercial » Project
Yposkesi, France
François Gianelli
Senior Director CMC
Voisin Consulting
Michel Degueldre
Lead GT Analytics Physico-Chemical methods
UCB Pharma, Belgium
Antoine Heron
Cell & Gene Therapy Bioprocessing
Merck, France
15h00
Coffee Break – Exhibition Hall – B2B Meetings
15h30
Track Process characterization and validation for mAbs and Vaccins : case-studies
Elodie Lim
Upstream Process Engineer
SANOFI & Marine De-Jaeger, SANOFI
Thibault Lasgouzes
Downstream Process Expert 2
Novartis
Jérôme King
Biostatisticien
MERCK, Switzerland
Track Process characterization and validation for cell & gene therapy : case-studies
Gregory Berger
Principal Scientist Cell & Gene Therapy
Celonic, Switzerland
16h30
Breakthrough Innovations in Bioproduction
17h10
Round table: How to bring single-use disposables and consumables suppliers back to Europe: challenges & opportunites
Philippe Gomez
Key Account Manager
Sartorius, France
Eva Schaefer
Director Supply Robustness
Merck KGaA, Germany
Roland Beliard
CEO
LFB Biomanufacturing, France
19h00
Poster presentation- Exhibition Hall – Apero Cocktail
8h00
Welcome coffee
8h30
Opening Keynote Lecture
Dr. Amadou SALL
CEO
Institut Pasteur de Dakar, Sénégal
9h00
Track Stability studies of cell lines to speed up first in human trials: new technologies & approaches
Julien Douet
Head Cell Line Technologies
Merck
Regina Grillari
COO, CSO, co-founder
Evercyte
Track Viral Clearance in the Manufacture of Biologics: next generation strategies
Eric Forma
Scientist - Deputy Head of a Bioprocess Research & Development Unit
Sanofi Pasteur
Fabien Barbirato
Technology Innovation Director
Sanofi Pasteur
Anne Fournillier
Head of CMC Life Cycle Management, Pediatric and Booster vaccines
Sanofi Pasteur
Flavio Peroglio
Head of GMS Ivrea Quality Control & Scientific Excellence
MERCK
Sandra Bosshard
Team Lead - cell Culture Development
Lonza, Switzerland
10h20
Coffee Break – Exhibition Hall – B2B Meetings
11h00
Parallell Workshops
12h30
Lunch– Exhibition Hall – B2B Meetings
14h30
Breakthrough Innovations in Bioproduction
15h05
Track mRNA, a new platform technology and therapeutical approach: pros & cons
Nicolas Chaudet
Bioprocess R&D Unit head (microbiology / mRNA)
SANOFI Pasteur
Jose Castillo
CEO
Quantoom Biosciences
Arslan Akmammedov
Principal Scientist
Celonic
Pascale Bouillé
CEO
Flash Therapeutics, France
16h30
Closing remarks
16h40
Exhibition Hall – B2B Meetings
18h00
End of Congress
Submit your Abstract to give a Pitch presentation or present your Poster at the 7th edition Bioproduction Congress.
In order to provide visibility and promote innovation in the field of “CMC Readiness to accelerate biotherapeutics for patients”, a call is open to submit an abstract for a Pitch at Breakthrough Innovations in Bioproduction Session.
This is a great opportunity for start-ups, SMEs, and academic laboratories to share their new work!
The abstracts will be reviewed and the best selected for innovative products, technology, approaches and research.
Abstract submission deadline: June 17th, 2022
Check out the guidelines and fill-in the Abstract Form and send it to ana-sofia.antunes@mabdesign.fr
Abstract Submission Guidelines
Abstract Form